Erratum to: Genotype and co-medication dependent CYP2D6 metabolic activity: effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixol.

Patteet, Lisbeth; Haufroid, Vincent; Maudens, Kristof; Sabbe, Bernard; Morrens, Manuel; Neels, Hugo

doi:10.1007/s00228-016-2144-8

Erratum to: Genotype and co-medication dependent CYP2D6 metabolic activity: effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixol.

Patteet, Lisbeth

;

Haufroid, Vincent

;

Maudens, Kristof

;

Sabbe, Bernard

;

Neels, Hugo

;et.al.

(2017) European Journal of Clinical Pharmacology — Vol. 73, n° 1, p. 127 (2017)

Files

2017-Patteet_Eur_J_Clin_Pharmacol_Erratum.pdf

Restricted Access
Adobe PDF
186.97 KB

Request a copy

Details

Authors

Patteet, Lisbeth
Author
Haufroid, VincentUCLouvain
Author
Maudens, Kristof
Author
Sabbe, Bernard
Author
Neels, Hugo
Author

Affiliations

Citations

APA
Chicago
FWB

Patteet, L., Haufroid, V., Maudens, K., Sabbe, B., Morrens, M., & Neels, H. (2017). Erratum to: Genotype and co-medication dependent CYP2D6 metabolic activity: effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixol. European Journal of Clinical Pharmacology, 73(1), 127. https://doi.org/10.1007/s00228-016-2144-8 (Original work published 2017)